Merck & Co Inc
NYSE:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Merck & Co Inc
NYSE:MRK
|
US |
|
M
|
Mattel Inc
DUS:MTT
|
US |
|
Citra Marga Nusaphala Persada Tbk PT
F:J7K
|
ID |
|
F
|
Fresenius SE & Co KGaA
F:FREA
|
DE |
|
P
|
Pharos Energy PLC
F:OCS1
|
UK |
|
Premium Brands Holdings Corp
F:5P7
|
CA |
|
F
|
Fomento de Construcciones y Contratas SA
DUS:FCC
|
ES |
|
Fukuyama Transporting Co Ltd
F:FUY
|
JP |
|
H
|
Hartford Insurance Group Inc
XMUN:HFF
|
US |
|
C
|
CNOOC Ltd
F:NC2B
|
CN |
|
Flugger group A/S
CSE:FLUG B
|
DK |
|
C
|
CNOOC Ltd
DUS:NC2B
|
CN |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
Nomura Micro Science Co Ltd
F:Q64
|
JP |
|
S
|
Shanghai Fudan Microelectronics Group Co Ltd
F:FUD
|
CN |
|
A
|
ALT Telecom PCL
SET:ALT
|
TH |
|
C
|
China Eastern Airlines Corp Ltd
OTC:CHEAF
|
CN |
|
Pyridam Farma Tbk PT
IDX:PYFA
|
ID |
|
P
|
PC Gold Ltd
ASX:PC2
|
AU |
|
A
|
Aeris Resources Ltd
OTC:ARSRF
|
AU |
Intrinsic Value
Is MRK undervalued or overvalued?
See the intrinsic value estimate for Merck & Co Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MRK looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with MRK’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Merck Does
Merck & Co. is a global drug company that makes prescription medicines, vaccines, and animal health products. Its best-known business is developing and selling branded drugs for cancer, infectious disease, diabetes, and other serious conditions. It also sells vaccines and medicines used by veterinarians and livestock producers.
- Headquarters
- United States of America US
- Employees
- 75 000
- IPO date
- Jan 1, 1941
Merck & has a wide economic moat
Legal protection for Merck’s medicines prevents rivals from freely selling copies, allowing it to earn more than it could in a market filled with cheaper alternatives. Its protected treatments span cancer, vaccines and other diseases, so this protection extends beyond a single medicine.
Read the full moat analysisLatest Earnings Call
Merck raised its revenue outlook as LIPFENDRA approval and earlier-than-expected pipeline readouts strengthened management’s confidence in diversifying beyond KEYTRUDA.
- EPS
- −$0.13
- Expected
- −$0.26
- Surprise
- +50.0%
- Stock, day of the call
- +0.2%
Revenue & Expenses Breakdown
Merck & Co Inc
Earnings Waterfall
Merck & Co Inc
The intrinsic value for Merck & Co Inc (MRK) under the Base Case is hidden USD.
Compared with the current market price of 148.8 USD, the stock appears hidden.